MedPath

Biocon Pharma, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

23

FDA:23

Drug Approvals

Liothyronine sodium

Approval Date
Apr 4, 2024
FDA

FINGOLIMOD

Approval Date
Feb 9, 2024
FDA

Pemetrexed

Approval Date
Jan 11, 2024
FDA

Atorvastatin Calcium

Approval Date
Nov 3, 2023
FDA

EVEROLIMUS

Approval Date
Jun 2, 2023
FDA

FAMOTIDINE

Approval Date
May 21, 2023
FDA

Teriflunomide

Approval Date
Jan 13, 2023
FDA

Prazosin hydrochloride

Approval Date
Jan 4, 2023
FDA

esomeprazole magnesium

Approval Date
Nov 16, 2022
FDA

VIGABATRIN

Approval Date
Nov 10, 2022
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.